Sorry, you need to enable JavaScript to visit this website.

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve.

Click here to learn how we are responding.

Skip to main content
Home

Main navigation

  • Homepage
  • About clinical trials

    About
    clinical trials

    Visit About Clinical Trials page

    About Trial submenu

    • How clinical trials work
    • Protecting your safety & privacy
    • Diversity in clinical trials
    • Steps to join a clinical trial
    • For caregivers
    • Pediatric clinical trials
    • FAQs
  • Our research

    Our research

    Visit Our Research page

    Our research submenu

    • Inflammation & Immunology
    • Internal Medicine
    • Oncology
    • Rare Diseases
    • Vaccines
    • Pfizer Clinical Research Unit (PCRU)
  • For participants

    For participants

    For participants

    • For current clinical trial participants
    • For past clinical trial participants
  • Find a trial

    Find a Pfizer clinical trial

    Sex
    Male
    Female
    Pediatric Trials: 0-17 Years
    Adult Trials: 18+ Years
    0 - 17
    18 - 64
    65+
    Indicates the current stage of a clinical study and whether it is or will be open for enrollment or in currently active and enrolling in the near future.
    • 50
    • 100
    • 150
    • 200
    • 250+
    250+
    1000
    Show Filters
    Male Female 0 - 17 Years 18 - 64 Years 65+ Years 50 100 150 200 250+
    loader

    Searching for Matching Trials ...

Contact us

For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.

34 trials found

Find a Pfizer clinical trial

Sex
Male
Female
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 - 17
18 - 64
65+
Indicates the current stage of a clinical study and whether it is or will be open for enrollment or in currently active and enrolling in the near future.
  • 50
  • 100
  • 150
  • 200
  • 250+
250+
1000
Show Filters
MaleFemale0 - 17 Years18 - 64 Years65+ Years50100150200250+
loader

Searching for Matching Trials ...

34 trials found for"Lung cancer"
  • Save search
  • Saved trials
PrintEmail
All (34)Recruiting (32)Not yet recruiting (2)
Non-Small Cell Lung Cancer, Carcinoma, Squamous Cell, Adenocarcinoma
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT02664935
Recruiting
Male or Female
18+
years
6570
Multiple Sites
6570
24study location(s)
Locations for this trial:
Aberdeen Royal Infirmary
Aberdeen
United Kingdom
Belfast City Hospital, Belfast Health and Social Care Trust
Belfast
United Kingdom
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust
Birmingham, B15 2GW
United Kingdom
Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust
Birmingham
United Kingdom
University Hospitals Bristol NHS Foundation Trust
Bristol
United Kingdom
Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust
Cambridge, CB2 0QQ
United Kingdom
Velindre Cancer Centre, Velindre NHS Trust
Cardiff, CF14 2TL
United Kingdom
Colchester General Hospital
Colchester
United Kingdom
Royal Devon and Exeter Hospital
Exeter
United Kingdom
Beatson West of Scotland Cancer Centre
Glasgow, G12 0YN
United Kingdom
St. James' University Hospital, Leeds Teaching Hospital NHS Trust
Leeds, LS9 7TF
United Kingdom
Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust
Leicester
United Kingdom
Royal Marsden Hospital, The Royal Marsden NHS Foundation Trust
London, SW3 6JJ
United Kingdom
Charing Cross Hospital, Imperial College Healthcare NHS Trust
London
United Kingdom
Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust
London
United Kingdom
St Bartholomew's Hospital, Barts Health NHS Trust
London
United Kingdom
University College Hospital, University College London Hospitals NHS Foundation Trust
London
United Kingdom
Maidstone Hospital
Maidstone
United Kingdom
The Christie Hospital, The Christie NHS Foundation Trust
Manchester
United Kingdom
Sir Bobby Robson Cancer Trial Research Centre, The Newcastle upon Tyne Hospitals
Newcastle, NE7 7DN
United Kingdom
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust
Oxford
United Kingdom
Weston Park Hospital, Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield
United Kingdom
Southampton General Hospital, University Hospital Southampton NHS Foundation Trust
Southampton, SO16 6YD
United Kingdom
Clatterbridge Cancer Centre
Wirral, CH63 4JY
United Kingdom
Non-small Cell Lung Cancer
Safety and Efficacy of Lorbrena
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT03844464
Recruiting
Male or Female
Tokyo,
1study location(s)
Locations for this trial:
3-22-7, Yoyogi, Shibuya-ku
Tokyo, 151-8589
Japan
Lung Cancer, Small-Cell Lung Cancer
Talazoparib and Thoracic RT for ES-SCLC
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT04170946
Recruiting
Male or Female
18+
years
6570
Toronto, Ontario
6570
1study location(s)
Locations for this trial:
Princess Margaret Cancer Center, University Health Network
Toronto, Ontario, M5G 2M9
Canada
Metastatic Non Small Cell Lung Cancer
Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT04511533
Recruiting
Male or Female
18+
years
6570
Multiple Sites
6570
13study location(s)
Locations for this trial:
Rajiv Gandhi Cancer Institute And Research Centre
New Delhi, Delhi, 110085
India
The Gujarat Cancer and Research Institute
Ahmedabad, Gujarat, 380016
India
Hemato Oncology Clinic Ahmedabad Pvt. Ltd
Ahmedabad, Gujarat, 380054
India
Artemis Hospital
Gurugram, Haryana, 122001
India
National Cancer Institute
Nagpur, Maharashtra, 441108
India
Apex Wellness Hospital
Nashik, Maharashtra, 422009
India
Sahyadri Super Speciality Hospital
Pune, Maharashtra, 41004
India
Grant Medical Foundation, Ruby Hall Clinic
Pune, Maharashtra, 411001
India
Sahyadri Clinical Research & Development Centre
Pune, Maharashtra, 411004
India
Sahyadri Super Speciality Hospital
Pune, Maharashtra, 411004
India
Bhaktivedanta Hospital and Research Institute
Thane, Maharashtra, 401107
India
Yashoda Hospital
Hyderabad, Telangana State, 500082
India
Tata Medical Center
Kolkata, WEST Bengal, 700160
India
Lung Cancer, Anaplastic Lymphoma Kinase Gene Translocation, ROS1 Rearrangement, Relapsed Cancer, MET Amplification, Resistant Cancer, NSCLC
Lorlatinib Combinations in Lung Cancer
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT04292119
Recruiting
Male or Female
18+
years
6570
Multiple Sites
6570
2study location(s)
Locations for this trial:
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114
United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215
United States
Carcinoma, Non-Small-Cell Lung
A Study Of Lorlatinib Versus Crizotinib In First Line Treatment Of Patients With ALK-Positive NSCLC
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT03052608
Recruiting
Male or Female
18+
years
6570
Multiple Sites
6570
50study location(s)
Locations for this trial:
Centro de Investigacion Pergamino SA
Pergamino, Buenos Aires, B2700CPM
Argentina
Centro Medico Austral
Caba, C1019ABS
Argentina
Bendigo Day Surgery Collection Centre and Laboratory
Bendigo, Victoria, 3550
Australia
Bendigo Medical Imaging, Bendigo Hospital
Bendigo, Victoria, 3550
Australia
Melbourne Pathology
Bendigo, Victoria, 3550
Australia
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000
Australia
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9
Canada
McGill University Health Centre
Montreal, Quebec, H4A 3J1
Canada
Shanghai Chest Hospital
Shanghai, Shanghai, 200030
China
Vseobecna fakultni nemocnice v Praze
Praha 2, 128 08
Czechia
Centre Hospitalier du Mans
Le Mans, 72000
France
Institut Paoli-Calmettes
Marseille cedex 09, 13273
France
Département d'Imagerie Médicale
Marseille cedex 20, 13915
France
Hôpital Nord
Marseille cedex 20, 13915
France
Service Ophtalmologie
Marseille cedex 20, 13915
France
Clinique Monticelli-Paradis-Dr Stephan Fauquier
Marseille, 13008
France
Thoraxklinik Heidelberg gGmbH
Heidelberg, D-69126
Germany
Universitatsklinikum Heidelberg
Heidelberg, D-69126
Germany
Universitätsklinikum des Saarlandes, Innere Medizin V
Homburg - Saar, 66421
Germany
Universitätsklinikum des Saarlandes
Homburg - Saar, 66421
Germany
Universitatsklinikum Regensburg, Institut fur Rontgendiagnostik
Regensburg, 93053
Germany
Universitatsklinikum Regensburg, Klinik und Poliklinik fur Innere Medizin II
Regensburg, 93053
Germany
ASST Monza - A.O. San Gerardo
Monza, MB, 20900
Italy
Fondazione IRCCS Istituto Nazionale dei Tumori
Milano, MI, 20133
Italy
Istituto Europeo di Oncologia
Milano, MI, 20141
Italy
Istituto Clinico Humanitas
Rozzano, MI, 20089
Italy
Azienda Ospedaliera di Perugia - Ospedale S. M. Misericordia
Perugia, PG, 06132
Italy
Centro di Riferimento Oncologico-IRCCS
Pordenone, PN, 33081
Italy
Az.Osp.San Camillo-Forlanini
Roma, RM, 00152
Italy
Azienda Ospedaliera Dei Colli Ospedale Monaldi
Napoli, 80131
Italy
Istituto Nazionale Tumori di Napoli
Napoli, 80131
Italy
Seoul National University Hospital
Seoul, 03080
Korea, Republic of
Ulsan University Hospital
Ulsan, 44033
Korea, Republic of
Promotora Medica Aguascalientes SA de CV
Aguascalientes, 20230
Mexico
Instituto Nacional de Cancerologia
Distrito Federal, 14080
Mexico
Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Distrito Federal, 14080
Mexico
University Medical Center Groningen
Groningen, 9713 GZ
Netherlands
Med-Polonia Sp. z o.o.
Poznan, 60-693
Poland
Centrum Medyczne Dom Lekarski S.A.
Szczecin, 70-784
Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie-Panstwowy Instytut Badawczy
Warszawa, 02-781
Poland
Budgetary Healthcare Institution Omsk Region "Clinical Oncological Dispensary"
Omsk, OMSK Region, 644013
Russian Federation
LEC at SBIH "Saint-Petersburg Clinical Research Practical Center of specialized types of
Pesochniy Poselok, Saint-petersburg, 197758
Russian Federation
Private Medical Institution "Euromedservice"
Pushkin, Saint-petersburg, 196603
Russian Federation
FSBI "N.N.Blokhin Medical Research Center of Oncology"
Moscow, 115478
Russian Federation
Hospital Teresa Herrera C.H.U.A.C.
A Coruna, 15006
Spain
Hospital Universitari Vall d'Hebron
Barcelona, 08035
Spain
Hospital Clinic i Provincial de Barcelona
Barcelona, 08036
Spain
Institut Catala d'Oncologia Girona
Girona, 17007
Spain
National Taiwan University Hospital
Taipei, Taiwan ROC, 10002
Taiwan
Taipei Veterans General Hospital
Taipei, 112
Taiwan
Solid Tumor, Non Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma
GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT04601402
Recruiting
Male or Female
18+
years
6570
Multiple Sites
6570
3study location(s)
Locations for this trial:
Yale Cancer Center
New Haven, Connecticut, 06510
United States
Emory University Winship Cancer Institute
Atlanta, Georgia, 30322
United States
Oregon Health & Science University
Portland, Oregon, 97239
United States
Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma, Ovarian Cancer, Gastric Cancer, Esophageal Cancer, Lung Squamous Cell Carcinoma, Pancreatic Cancer, Bile Duct Cancer, Endometrial Cancer, Melanoma Cancer, Urothelial Cancer
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT04152018
Recruiting
Male or Female
18+
years
6570
Multiple Sites
6570
14study location(s)
Locations for this trial:
Scottsdale Healthcare Hospitals DBA HonorHealth
Scottsdale, Arizona, 85258
United States
Virginia G. Piper Cancer Pharmacy
Scottsdale, Arizona, 85258
United States
Ronald Reagan UCLA Medical Center
Los Angeles, California, 90095
United States
UCLA Hematology Oncology
Los Angeles, California, 90095
United States
UCLA Hematology/Oncology
Los Angeles, California, 90095
United States
Siteman Cancer Center - West County
Creve Coeur, Missouri, 63141
United States
Barnes-Jewish Hospital
Saint Louis, Missouri, 63110
United States
Washington University School of Medicine Siteman Cancer Center
Saint Louis, Missouri, 63110
United States
Siteman Cancer Center - South County
Saint Louis, Missouri, 63129
United States
Siteman Cancer Center - North County
Saint Louis, Missouri, 63136
United States
Siteman Cancer Center - St. Peters
Saint Peters, Missouri, 63376
United States
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030
United States
NEXT Oncology
San Antonio, Texas, 78229
United States
University of Washington Medical Center
Seattle, Washington, 98195
United States
Locally Advanced or Metastatic ER+ HER2- Breast Cancer, Locally Advanced or Metastatic Castration-resistant Prostate Cancer, Locally Advanced or Metastatic Non-small Cell Lung Cancer
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT04606446
Recruiting
Male or Female
18+
years
6570
Multiple Sites
6570
7study location(s)
Locations for this trial:
Tennessee Oncology PLLC
Franklin, Tennessee, 37067
United States
Sarah Cannon Research Institute
Nashville, Tennessee, 37203
United States
Tennessee Oncology PLLC
Nashville, Tennessee, 37203
United States
The Sarah Cannon Research Institute / Tennessee Oncology, PLLC
Nashville, Tennessee, 37203
United States
NEXT Oncology
San Antonio, Texas, 78229
United States
National Cancer Center Hospital East
Kashiwa, Chiba, 277-8577
Japan
National Cancer Center Hospital
Chuo-ku, Tokyo, 104-0045
Japan
Non-squamous Non-small-cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, ROS1 Gene Rearrangement, MET Activating Mutation, MET Amplification
Study of Crizotinib for ROS1 and MET Activated Lung Cancer
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT04084717
Recruiting
Male or Female
18+
years
6570
Toronto, Ontario
6570
1study location(s)
Locations for this trial:
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 1Z5
Canada

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next pageNext ›
  • Last pageLast »

Saved trials

You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

Information on this website is directed toward U.S. residents only.

© 2020 Pfizer Inc. All rights reserved.

Social links menu

  • Facebook
  • Youtube
  • Instagram

Footer

  • About Pfizer
  • For investigators
  • Contact us

Footer menu

  • Site map
  • Terms of use
  • Privacy policy